Synthesis of a fully benzenoid phenothiazinium ion for red-light-driven photocatalysis
Chemical Communications · 2026
DOI: 10.1039/d6cc05300a ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2026. Verfasst von Sebastiano Pallanch und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Pharmaceutical Sciences, INSTM UdR Trieste, University of Trieste, via Licio Giorgieri 1, Trieste 34127, Italy. Jacopo.dos…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Università degli Studi di Trieste.
Abstract (Originalsprache)
A novel fully benzenoid phenothiazinium ion has been synthesized and employed for the first time as an orange/red-light photocatalyst.
Autor:innen und Institutionen
- Department of Chemical and Pharmaceutical Sciences, INSTM UdR Trieste, University of Trieste, via Licio Giorgieri 1, Trieste 34127, Italy. Jacopo.dosso@units.it.
- Departamento de Química Orgánica I, Instituto de Innovación En Química Avanzada (ORFEO-CINQA), University of the Basque Country (UPV/EHU), Paseo Manuel Lardizabal 3, Donostia/San Sebastián 20018, Spain.
- Donostia International Physics Center (DIPC), Paseo Manuel Lardizabal 4, Donostia/San Sebastián 20018, Spain.
Förderung
- Università degli Studi di Trieste
Zitieren
APA
Pallanch, S., Tosoratti, R., Cossío, F. P., & Dosso, J. (2026). Synthesis of a fully benzenoid phenothiazinium ion for red-light-driven photocatalysis. Chemical Communications. https://doi.org/10.1039/d6cc05300a
Vancouver
Pallanch S, Tosoratti R, Cossío FP, Dosso J. Synthesis of a fully benzenoid phenothiazinium ion for red-light-driven photocatalysis. Chemical Communications. 2026. doi:10.1039/d6cc05300a
BibTeX
@article{Pallanch2026,
author = {Pallanch, Sebastiano and Tosoratti, Riccardo and Cossío, Fernando P and Dosso, Jacopo},
title = {Synthesis of a fully benzenoid phenothiazinium ion for red-light-driven photocatalysis},
journal = {Chemical Communications},
year = {2026},
doi = {10.1039/d6cc05300a}
}
EUVIMED